FTSE100

Dr. John Bates named CEO; SER sets up team for accelerated growth

Retrieved on: 
Tuesday, January 25, 2022
Technology, M&A, Growth, CEO, Doxie, ECM, Automation, Bates, Software as a service, SER, Internet, FTSE100, BPM, Collaboration, Organization, Management, Eggplant

BONN, Germany, Jan. 25, 2022 /PRNewswire-PRWeb/ --Effective immediately, SERgroup Holding International GmbH (SER) is pleased to announce that Dr. John Bates has been named Chief Executive Officer.

Key Points: 
  • BONN, Germany, Jan. 25, 2022 /PRNewswire-PRWeb/ --Effective immediately, SERgroup Holding International GmbH (SER) is pleased to announce that Dr. John Bates has been named Chief Executive Officer.
  • Furthermore, SER has enhanced its management team with several new appointments in finance, sales, product management and customer success.
  • In taking up the CEO role, Bates has moved from the role as Executive Chairman of SER.
  • With 35 years of experience, the SER Group's team of over 630 employees works from 22 locations around the globe.

Smith+Nephew's PICO™ 7 and PICO 14 Negative Pressure Wound Therapy Systems are the first systems indicated to aid in reducing the incidence of both deep and superficial incisional surgical site infections and dehiscence

Retrieved on: 
Monday, January 24, 2022
SSIS, U.S. Securities and Exchange Commission, ENT, Forward-looking statement, Patient, Technology, Annual report, Charles T. Horner Jr., NPWT, Longevity, Mete, LinkedIn, International, Reece Styche, United States Patent and Trademark Office, SNN, Smith & Nephew, Meta-analysis, NYSE, Form 20-F, Regeneration, Wound, DOF, PICO, Instagram, Unlimited, View, Sports medicine, Phrase, Patent, Multimedia, LSE, Twitter, FTSE100, United States patent law, Failure, Group, Medicine, Fertilizer, Pharmaceutical industry, Orthopedic surgery, McNish, COVID-19, Facebook

Shanmugam, V. K., Fernandez, S. J., Evans, K. K., McNish, S., Banerjee, A. N., Couch, K. S., Mete, M., & Shara, N. (2015).

Key Points: 
  • Shanmugam, V. K., Fernandez, S. J., Evans, K. K., McNish, S., Banerjee, A. N., Couch, K. S., Mete, M., & Shara, N. (2015).
  • Postoperative wound dehiscence: Predictors and associations.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society,23(2), 184190. https://doi.org/10.1111/wrr.12268
    Najjar PA, Smink DS.
  • Dowsett C, Hampton K, Myers D, Styche T. Use of PICO to improve clinical and economic outcomes in hard-to-heal wounds.
  • 2017;8(2):52-58
    Saunders C, Nherera LM, Horner A, Trueman P. Single-Use negative-pressure wound therapy versus conventional dressings for closed surgical incisions: systematic literature review and meta-analysis.

MGM RESORTS AND ENTAIN ANNOUNCE BETMGM BUSINESS UPDATE

Retrieved on: 
Wednesday, January 19, 2022
GAAP, Carbon, Ladbrokes Coral, International, Omnichannel, Private Securities Litigation Reform Act, NYSE, Sport, U.S. Securities and Exchange Commission, MGM, Industry, MGM Resorts International, FTSE100, LLC, Revenue, Technology, MSCI, PartyCasino, FY, Adult, Instagram, Gambling, LSE, Internet, Partnership, ESG, Fortune (magazine), EBITDA, Borgata, Group, Growth, Facebook, Entain, IGaming Business, Acquisition, DJSI, Net, AA, Population, Karhu (sports brand), FTSE4Good Index, Magazine, Twitter, Security (finance), Hotel, Online gambling, Health insurance, Risk management, Renewable energy, Bank, Sportingbet, Gala Bingo

LAS VEGAS, Jan. 19, 2022 /PRNewswire/ --BetMGM, LLC ("BetMGM"), one of the leading sports betting and iGaming operators across the U.S., jointly owned by MGM Resorts International (NYSE: MGM) ("MGM Resorts") and Entain plc (LSE: ENT) ("Entain"), is today providing an update on performance and outlook for 2022.

Key Points: 
  • LAS VEGAS, Jan. 19, 2022 /PRNewswire/ --BetMGM, LLC ("BetMGM"), one of the leading sports betting and iGaming operators across the U.S., jointly owned by MGM Resorts International (NYSE: MGM) ("MGM Resorts") and Entain plc (LSE: ENT) ("Entain"), is today providing an update on performance and outlook for 2022.
  • These achievements are underpinned by the structural advantages offered through MGM Resorts and Entain as well as a best-in-class team at BetMGM led by Adam.
  • As we look to 2022, we are beyond excited about further integrating BetMGM with our MGM loyalty program and land-based operations to elevate the BetMGM player experience.
  • Born out of a partnership between MGM Resorts International (NYSE: MGM) and Entain Plc (LSE: ENT), BetMGM has exclusive access to all of MGM Resorts' U.S. land-based and online sports betting, major tournament poker, and online gaming businesses.

Smith+Nephew opens new commercial hub in Copenhagen, Denmark to better serve customers across the Nordic region

Retrieved on: 
Thursday, January 6, 2022
SNN, Longevity, Failure, ENT, Forward-looking statement, NYSE, Unlimited, Group, Smith & Nephew, U.S. Securities and Exchange Commission, Twitter, LSE, United States Patent and Trademark Office, LinkedIn, Instagram, Patent, Form 20-F, Sports medicine, FTSE100, Travel, Phrase, Technology, Annual report, United States patent law, Management, COVID-19, Orthopedic surgery, Facebook

LONDON, Jan. 62022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the grand opening of a new commercial hub to better serve customers across the Nordic region.

Key Points: 
  • LONDON, Jan. 62022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the grand opening of a new commercial hub to better serve customers across the Nordic region.
  • The new office, in the restad area of Copenhagen, Denmark, was opened by members of the management team in December 2021.
  • Smith+Nephew has invested in new central positions that support customers and sales teams better for supply planning and tender support.
  • To further support customers, in late Spring 2022 Smith+Nephew will also open a new distribution centre in Gothenburg, Sweden, to manage product loans, service and repair across the Nordic region.

Smith+Nephew launches 'turn-key' robotic-assisted surgical system; designed to quickly augment the orthopaedic team's skills set for greater accuracy(1-3) ¥ improved outcomes(4), and potentially an immediate scalable solution to NHS

Retrieved on: 
Tuesday, November 23, 2021
Surgeon, Comparison, Death, United States Patent and Trademark Office, NYSE, LCP, Longevity, Belle Meade, Tennessee, Chronic pain, Tat, LinkedIn, SNN, Heart, Prom, Time, Robotics, Group, LSE, ENT, View, Phrase, Patient, Failure, CORI, Unlimited, Pulitzer Prize for International Reporting, Sports medicine, Seein' Red, White 'N' Blue, Physiology, Forward-looking statement, Shearman & Sterling, Smith & Nephew, U.S. Securities and Exchange Commission, Software, Twitter, 24 Hours, MP, The Bone & Joint Journal, Multimedia, The Journal of Bone and Joint Surgery, Quality of life, Springer, Patent, Technology, Hip, NHS foundation trust, Anatomy, Annual report, Form 20-F, United States patent law, FTSE100, Instagram, Unicompartmental knee arthroplasty, Dentistry, Hospital, Medicine, Pharmaceutical industry, Sports equipment, Television

LONDON, Nov. 23, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the launch of CORI™ handheld robotics, an advanced system for both total and partial knee arthroplasties.

Key Points: 
  • The CORI system is a compact and fully mobile5 solution incorporating a 3-D intra-operative imaging system with an advanced robotic sculpting tool.
  • We know that outcomes aren't consistent in non-robotic surgeries and that one in five patients15-20 have issues following surgery.
  • The CORI system is amongst the first technology to place the surgeon at the heart of the digital operating room.
  • Surgeons can access the benefits of robotic surgery but still have full decision-making capability at each step of the operation.

Smith+Nephew launches 'turn-key' robotic-assisted surgical system; designed to quickly augment the orthopaedic team's skills set for greater accuracy(1-3) ¥ improved outcomes(4), and potentially an immediate scalable solution to NHS

Retrieved on: 
Tuesday, November 23, 2021
Surgeon, Comparison, Death, United States Patent and Trademark Office, NYSE, LCP, Longevity, Belle Meade, Tennessee, Chronic pain, Tat, LinkedIn, SNN, Heart, Prom, Time, Robotics, Group, LSE, ENT, Phrase, Patient, Failure, CORI, Unlimited, Pulitzer Prize for International Reporting, Sports medicine, Seein' Red, White 'N' Blue, Physiology, Forward-looking statement, Shearman & Sterling, Smith & Nephew, U.S. Securities and Exchange Commission, Software, Twitter, 24 Hours, MP, The Bone & Joint Journal, The Journal of Bone and Joint Surgery, Quality of life, Springer, Patent, Technology, Hip, NHS foundation trust, Anatomy, Annual report, Form 20-F, United States patent law, FTSE100, Instagram, Unicompartmental knee arthroplasty, Dentistry, Hospital, Medicine, Pharmaceutical industry, Sports equipment, Television

The CORI system is a compact and fully mobile5 solution incorporating a 3-D intra-operative imaging system with an advanced robotic sculpting tool.

Key Points: 
  • The CORI system is a compact and fully mobile5 solution incorporating a 3-D intra-operative imaging system with an advanced robotic sculpting tool.
  • We know that outcomes aren't consistent in non-robotic surgeries and that one in five patients15-20 have issues following surgery.
  • The CORI system is amongst the first technology to place the surgeon at the heart of the digital operating room.
  • Surgeons can access the benefits of robotic surgery but still have full decision-making capability at each step of the operation.

Australia's Tech Advantage - How is Technology transforming businesses and economy? - Topic of the latest webinar going to be hosted by Kalkine Media on November 25, 2021

Retrieved on: 
Thursday, November 18, 2021
Cloud, News, Automation, CEO, No Code, Technology, Industry, Google, Google Cloud, Blockchain, Tech, XETRA, Aircraft, COVID-19, Google Workspace, AEDT, FTSE100, ASX200

AI, blockchain and quantum computing are the new buzzwords presenting significant opportunities for people, businesses, and the broader economy.

Key Points: 
  • AI, blockchain and quantum computing are the new buzzwords presenting significant opportunities for people, businesses, and the broader economy.
  • Not to mention is the Australia's Tech Advantage with businesses embracing technology efficiently and effectively.
  • As we emerge from the challenges of the COVID-19 pandemic, a thriving digital economy is critical to Australia's overall economic recovery.
  • Get insights on Australia's Tech Future from three of Kalkine Media's valued clients - Aerologix Pty Ltd, Jaaims Australia & Zenphi Pty Ltd.

Stephen Bampfylde of Saxton Bampfylde & Ben Johnson of Sheffield Haworth Presented with Executive Search Industry Awards by AESC

Retrieved on: 
Wednesday, November 17, 2021
Government, Disability, CEO, Consultant, IBM, Industry, Access, Guildford, Partnership, Awareness, Marketing, Mentorship, REACH, Group, Gerald Loeb Lifetime Achievement Award winners, Equity, Yvonne Arnaud, Cambridge Judge Business School, Leadership, Chair, Jesus College, Interim, Economics, Goal, List of lifetime achievement awards, Digital Bananas Technology, Technology, College of Business, City University of Hong Kong, Whitehall, Change, FTSE100, Organization, Business school, Digital, Name, AMR Corporation, Inclusion, London Business School, Association, Operation, Management

AESC presents the Lifetime Achievement Award to Stephen Bampfylde , co-founder & Chair, Saxton Bampfylde .

Key Points: 
  • AESC presents the Lifetime Achievement Award to Stephen Bampfylde , co-founder & Chair, Saxton Bampfylde .
  • Stephen has been a leader in the drive for executive search firms to play a more significant role in advancing diversity goals.
  • Stephen began his career working for IBM and Whitehall, where he spent nearly 10 years before moving into executive search.
  • At Sheffield Haworth, Ben has become the LGBTQ+ Group leader, a new initiative since he joined the firm in 2019.

Smith+Nephew announces digital surgery and robotics innovation centre in Europe

Retrieved on: 
Tuesday, November 16, 2021
View, Robotics, CORI, United States Patent and Trademark Office, Group, ENT, LSE, U.S. Securities and Exchange Commission, Heart, Longevity, Technology, Failure, United States patent law, Instagram, EMEA, Sports medicine, Multimedia, Forward-looking statement, Unlimited, Form 20-F, Annual report, Twitter, SNN, LinkedIn, Phrase, Brainlab, Smith & Nephew, NYSE, Uwe Schmidt, FTSE100, Patent, Surgeon, Medical device, Management, Pharmaceutical industry

LONDON, Nov. 16,2021 /PRNewswire/ --Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is proud to announce the creation of a purpose built digital surgery and robotics innovation centre, based in Munich, Germany.

Key Points: 
  • LONDON, Nov. 16,2021 /PRNewswire/ --Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is proud to announce the creation of a purpose built digital surgery and robotics innovation centre, based in Munich, Germany.
  • The new innovation centre will bring healthcare professionals from Europe, Middle East and Africa together with Smith+Nephew's R&D and medical education teams to explore digital surgery and robotics techniques and technologies.
  • At the heart of this will be Real Intelligence, Smith+Nephew's digital ecosystem, including the new state-of-the-art robotics-assisted surgical system CORI.
  • The centre will also home Smith+Nephew's digital surgery and robotics R+D team, enabling them to collaborate with surgeons, scientists and engineers, driving innovation that meets unmet clinical needs.

Smith+Nephew announces digital surgery and robotics innovation centre in Europe

Retrieved on: 
Tuesday, November 16, 2021
Robotics, CORI, United States Patent and Trademark Office, Group, ENT, LSE, U.S. Securities and Exchange Commission, Heart, Longevity, Technology, Failure, United States patent law, Instagram, EMEA, Sports medicine, Forward-looking statement, Unlimited, Form 20-F, Annual report, Twitter, SNN, LinkedIn, Phrase, Brainlab, Smith & Nephew, NYSE, Uwe Schmidt, FTSE100, Patent, Surgeon, Medical device, Management, Pharmaceutical industry

LONDON, Nov. 16,2021 /PRNewswire/ --Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is proud to announce the creation of a purpose built digital surgery and robotics innovation centre, based in Munich, Germany.

Key Points: 
  • LONDON, Nov. 16,2021 /PRNewswire/ --Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is proud to announce the creation of a purpose built digital surgery and robotics innovation centre, based in Munich, Germany.
  • The new innovation centre will bring healthcare professionals from Europe, Middle East and Africa together with Smith+Nephew's R&D and medical education teams to explore digital surgery and robotics techniques and technologies.
  • At the heart of this will be Real Intelligence, Smith+Nephew's digital ecosystem, including the new state-of-the-art robotics-assisted surgical system CORI.
  • The centre will also home Smith+Nephew's digital surgery and robotics R+D team, enabling them to collaborate with surgeons, scientists and engineers, driving innovation that meets unmet clinical needs.